Tag Archives: publishing model

Open Access study in Europe shows ~10% of articles published in OA journals

Posted on by

“ Study of Open Access Pub­lish­ing project presents find­ings of two-year EC funded study on OA pub­lish­ing — 17 Jan 2011

The SOAP (Study of Open Access Pub­lish­ing) project pre­sented the results of its two-year Euro­pean Com­mis­sion (EU) funded exam­i­na­tion of open access pub­lish­ing at an open sym­po­sium on Jan­u­ary 13, 2011, in Berlin, Ger­many. Over the two-year study dura­tion, the SOAP project per­formed a com­pre­hen­sive study of open access jour­nals, pub­lish­ers and busi­ness mod­els, includ­ing analy­sis of pub­lish­ing houses, learned soci­eties and licens­ing along with the over­all sup­ply and demand for open access.

The study sur­veyed over 50,000 researchers for their opin­ions on open-access jour­nals, which make all their papers freely avail­able online and usu­ally charge authors a fee for each pub­lished paper. Accord­ing to the study, while sci­en­tists like open-access papers as read­ers, as authors, they are still skep­ti­cal. The study found over­whelm­ing sup­port for the con­cept, with 89 per­cent of respon­dents stat­ing that open access is ben­e­fi­cial to their field. How­ever, this sup­port did not always trans­late into action, the study noted. While 53 per­cent of respon­dents said they had pub­lished at least one open-access arti­cle, over­all only about 10 per­cent of papers are pub­lished in open access journals.

The study found two main rea­sons as to why researchers do not sub­mit their work to open-access jour­nals. About 40 per­cent said that a lack of fund­ing for author fees was a deter­rent, while 30 per­cent cited a lack of high-quality open-access jour­nals in their field.

Requir­ing authors to make sure the results of their work are freely avail­able has report­edly had only par­tial suc­cess. Robert Kiley, head of dig­i­tal ser­vices at the Well­come Trust’s Well­come Library in Lon­don, said at the sym­po­sium that open-access rates had risen from 12 per­cent to 50 per­cent since the fun­der began requir­ing its grantees to pub­lish in open-access jour­nals or deposit their papers in a freely avail­able repos­i­tory. How­ever, Kiley acknowl­edged that Well­come Trust had not imposed sanc­tions on researchers who failed to comply.

The study also makes it clear that open-access jour­nals are pro­lif­er­at­ing, espe­cially among small pub­lish­ers. It was observed that one-third of open-access papers were pub­lished by the more than 1600 open-access pub­lish­ers that pub­lish only a sin­gle jour­nal. The study also iden­ti­fied 14 ‘large pub­lish­ers’ that pub­lish either more than 50 jour­nals or more than 1000 arti­cles per year. The group accounts for roughly one-third of open-access pub­li­ca­tions, the study noted.”

Source:  Knowl­edge­s­peak Newslet­ter, 1/17/11

Open Access & Article Depostion from Nature Pub. Group

Posted on by

 Nature Pub­lish­ing Group and ASGT announce open access and arti­cle depo­si­tion ser­vices for authors — 26 Jan 2009

Sci­en­tific pub­lisher Nature Pub­lish­ing Group (NPG), UK, and the Amer­i­can Soci­ety of Gene Ther­apy (ASGT) have announced the launch of two new ser­vices to help authors com­ply with fun­der and insti­tu­tional man­dates for pub­lic access. Under the ini­tia­tive, Mol­e­c­u­lar Ther­apy, the offi­cial jour­nal of the ASGT, will now offer authors the option of imme­di­ate open access on pub­li­ca­tion, includ­ing depo­si­tion in PubMed Cen­tral, sub­ject to the pay­ment of a pub­li­ca­tion fee. In addi­tion, as a fur­ther author ben­e­fit to aid com­pli­ance with sev­eral fund­ing body man­dates, NPG will deposit all Mol­e­c­u­lar Ther­apy arti­cles to PubMed Cen­tral upon final pub­li­ca­tion, to be made pub­lic after 12 months.

Upon sub­mis­sion of orig­i­nal research arti­cles, authors have the option of pub­lish­ing their arti­cles as open access for a pub­li­ca­tion fee of £2,000 / $3,000 / €2,400. Open access arti­cles will be freely avail­able upon pub­li­ca­tion. By pay­ing this one-time fee, authors are also enti­tled to self-archive the final pub­lished PDF of their arti­cles on a web­site, insti­tu­tional repos­i­tory, or other free pub­lic server upon pub­li­ca­tion. Open access arti­cles will be des­ig­nated by the MTOpen logo in both the print and online edi­tions of the jour­nal and will be freely acces­si­ble via PubMed Cen­tral imme­di­ately after publication.

Open access arti­cles will be pub­lished under a Cre­ative Com­mons license. Authors may choose between the Attribution-Noncommercial-No Deriv­a­tive Works 3.0 Unported and the Attribution-Noncommercial-Share Alike 3.0 Unported Licence. The Attribution-Noncommercial-Share Alike Licence per­mits deriv­a­tive works, ensur­ing that authors can com­ply with fun­ders such as the Well­come Trust. Under both licenses, the final pub­lished ver­sion of MTOpen arti­cles can be down­loaded and shared as long as the author and orig­i­nal pub­li­ca­tion are cited.

Under the terms of NPG’s License to Pub­lish, self-archiving is encour­aged on all orig­i­nal research arti­cles pub­lished in Mol­e­c­u­lar Ther­apy. In all cases, the author’s ver­sion of the accepted man­u­script can be made pub­licly acces­si­ble six months after pub­li­ca­tion. This applies regard­less of whether the authors choose the MTOpen option.

Mol­e­c­u­lar Ther­apy joins The EMBO Jour­nal, EMBO reports and British Jour­nal of Can­cer, which already offer an open access option to authors. NPG also announced the intro­duc­tion of an open access option on ten fur­ther journals.

Click here
 

Knowl­edge­s­peak Newslet­ter, 26 Jan., 2009